NRG1 and schizophrenia: ErbB4 hyperactivation-directed treatment studies, such as those performed in T-Nrg1 mice,15 will allow to test the predictive validity of NC-Nrg1 mice and provide an entry point for the development of more potent treatment strategies that target specific endophenotypes in schizophrenia.